October 6, 2021 -- Twist Bioscience has expanded its Alliance Panel offering to include products designed by expert collaborators that have a wide range of clinical applications.
In exchange for their participation, expert collaborators will receive a royalty on product sales and will carry partner branding, the company said. Twist's new Twist Alliance Pan-Cancer Methylation Panel is based on the Cancer Genome Atlas (TCGA) database, which includes 31 cancer types and 47 TCGA database disease entities.
In validation studies using tumor biopsy samples, DNA methylation regions included in the panel differentiated cancer tissues from nonmalignant tissue in breast, colorectal, and non-small cell lung cancers, according to Twist.
Copyright © 2021 scienceboard.net